Prevention and management of respiratory disease in young people with cerebral palsy: consensus statement

Noula Gibson, Amanda M Blackmore, Anne B Chang, Monica S Cooper, Adam Jaffe, Wee-Ren Kong, Katherine Langdon, Lisa Moshovis, Karolina Pavleski, Andrew C Wilson, Noula Gibson, Amanda M Blackmore, Anne B Chang, Monica S Cooper, Adam Jaffe, Wee-Ren Kong, Katherine Langdon, Lisa Moshovis, Karolina Pavleski, Andrew C Wilson

Abstract

Respiratory illness is the leading cause of mortality in children with cerebral palsy (CP). Although risk factors for developing chronic respiratory illness have been identified, comprehensive clinical care recommendations for the prevention and management of respiratory illness do not currently exist. We invited over 200 clinicians and researchers from multiple disciplines with expertise in the management of respiratory illness in children with CP to develop care recommendations using a modified Delphi method on the basis of the RAND Corporation-University of California Los Angeles Appropriateness Method. These recommendations are intended for use by the wide range of practitioners who care for individuals living with CP. They provide a framework for recognizing multifactorial primary and secondary potentially modifiable risk factors and for providing coordinated multidisciplinary care. We describe the methods used to generate the consensus recommendations, and the overall perspective on assessment, prevention, and treatment of respiratory illness in children with CP. WHAT THIS PAPER ADDS: The first consensus statement for preventing and managing respiratory disease in cerebral palsy (CP). Risk factors for respiratory disease in CP should be identified early. Individuals with CP at risk of respiratory disease require regular assessment of risk factors. Effective partnerships between multidisciplinary teams, individuals with CP, and families are essential. Treatment of respiratory disease in individuals with CP must be proactive.

© 2020 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.

References

    1. Blair E, Langdon K, McIntyre S, Lawrence D, Watson L. Survival and mortality in cerebral palsy: observations to the sixth decade from a data linkage study of a total population register and National Death Index. BMC Neurol 2019; 19: 111.
    1. Reid SM, Carlin JB, Reddihough DS. Survival of individuals with cerebral palsy born in Victoria, Australia, between 1970 and 2004. Dev Med Child Neurol 2012; 54: 353–60.
    1. Ryan JM, Peterson MD, Ryan N, et al. Mortality due to cardiovascular disease, respiratory disease, and cancer in adults with cerebral palsy. Dev Med Child Neurol 2019; 61: 924–8.
    1. Himmelmann K, Sundh W. Survival with cerebral palsy over five decades in Western Sweden. Dev Med Child Neurol 2015; 57: 762–7.
    1. Elema A, Zalmstra TA, Boonstra AM, Narayanan UG, Reinders‐Messelink HA, Putten VD. Pain and hospital admissions are important factors associated with quality of life in nonambulatory children. Acta Paediatr 2016; 105: e419–e25.
    1. Murphy NA, Hoff C, Jorgensen T, Norlin C, Young PC. Costs and complications of hospitalizations for children with cerebral palsy. Pediatr Rehabil 2006; 9: 47–52.
    1. Young NL, McCormick AM, Gilbert T, et al. Reasons for hospital admissions among youth and young adults with cerebral palsy. Arch Dis Child 2011; 92: 46–50.
    1. Meehan E, Reid SM, Williams K, et al. Tertiary paediatric emergency department use in children and young people with cerebral palsy. J Paediatr Child Health 2015; 51: 994–1000.
    1. Meehan E, Reid SM, Williams K, et al. Hospital admissions in children with cerebral palsy: a data linkage study. Dev Med Child Neurol 2017; 59: 512–9.
    1. Meehan E, Freed GL, Reid SM, et al. Tertiary paediatric hospital admissions in children and young people with cerebral palsy. Child Care Health Dev 2015; 1: 928–37.
    1. Blackmore AM, Bear N, Blair E, et al. Prevalence of symptoms associated with respiratory illness in children and young people with cerebral palsy. Dev Med Child Neurol 2016; 58: 780–1.
    1. Blackmore AM, Bear N, Blair E, et al. Predicting respiratory hospital admissions in young people with cerebral palsy. Arch Dis Child 2018; 103: 1119–24.
    1. Blackmore AM, Bear N, Langdon K, Moshovis L, Gibson N, Wilson A. Respiratory hospital admissions and emergency department visits in young people with cerebral palsy: 5‐year follow‐up. Arch Dis Child 2019; 1–2. 10.1136/archdischild-2019-317714
    1. Blackmore AM, Gibson N, Cooper MS, Langdon K, Moshovis L, Wilson AC. Interventions for management of respiratory disease in young people with cerebral palsy: A systematic review. Child Care Health Dev 2019; 45: 754–71.
    1. Smithers‐Sheedy H, Badawi N, Blair E, et al. What constitutes cerebral palsy in the twenty‐first century? Dev Med Child Neurol 2014; 56: 323–8.
    1. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol 2007; 109: 8–14.
    1. Brouwers M, Kho M, Browman G, et al. AGREE II: advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J 2010; 182: E839–42.
    1. National Health Medical Research Council . Guide to the development, implementation and evaluation of clinical practice guidelines. Canberra, Australia: National Health Medical Research Council, 2009.
    1. Blackmore AM, Bear N, Blair E, et al. Factors associated with respiratory illness in children and young adults with cerebral palsy. J Pediatr 2016; 168: 151–7.
    1. Bear N, Blackmore A, Gibson N, et al. Validation of factors associated with respiratory hospitalizations in young people with cerebral palsy. Dev Med Child Neurol 2018; 60(Suppl 1): 50.
    1. Palisano R, Rosenbaum P, Bartlett D, Livingston M. Gross Motor Function Classification System–expanded and revised [Internet]. Available at (accessed 20 January 2020).
    1. Palisano R, Hanna S, Rosenbaum P, Russell D. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther 2000; 80: 974–85.
    1. O’Neil KH, Purdy M, Falk J, Gallo L. The dysphagia outcome and severity scale. Dysphagia 1999; 14: 139–45.
    1. Sellers D, Mandy A, Pennington L, Hankins M, Morris C. Development and reliability of a system to classify the eating and drinking ability of people with cerebral palsy. Dev Med Child Neurol 2014; 56: 245–51.
    1. Reid SM, McCutcheon J, Reddihough DS, Johnson H. Prevalence and predictors of drooling in 7‐ to 14‐year‐old children with cerebral palsy: a population study. Dev Med Child Neurol 2012; 54: 1032–6.
    1. Erasmus CE, Van Hulst K, Rotteveel LJC, et al. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Dev Med Child Neurol 2009; 51: 454–9.
    1. Erasmus CE, Van Hulst K, Rotteveel JJ, Willemsen MAAP, Jongerius PH. Swallowing problems in cerebral palsy. Eur J Pediatr 2012; 171: 409–14.
    1. Owayed AF, Campbell DM, Wang EEL. Underlying causes of recurrent pneumonia in children. Arch Pediatr Adolesc Med 2000; 154: 190–4.
    1. Faria J, Harb J, Hilton A, Yacobucci D, Pizzuto M. Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired children. Int J Pediatr Otorhinolaryngol 2015; 79: 2124–8.
    1. Gubbay A, Blackmore AM. Effects of salivary gland botulinum toxin‐A on drooling and respiratory morbidity in children with neurological dysfunction. Int J Pediatr Otorhinolaryngol 2019; 124: 124–8.
    1. Kim H, Lee Y, Weiner D, Kaye R, Cahill AM, Yudkoff M. Botulinum toxin type A injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Arch Phys Med Rehabil 2006; 87: 141–4.
    1. Meece RW, Fishlock KF, Bayley EW, Keller MS. Ultrasound‐guided botox injections of salivary glands in children with drooling. J Radiol Nurs 2010; 29: 20–4.
    1. Manrique D, Sato J. Salivary gland surgery for control of chronic pulmonary aspiration in children with cerebral palsy. Int J Pediatr Otorhinolaryngol 2009; 73: 1192–4.
    1. Noonan K, Prunty S, Ha JF, Vijayasekaran S. Surgical management of chronic salivary aspiration. Int J Pediatr Otorhinolaryngol 2014; 78: 2079–82.
    1. Vijayasekaran S, Unal F, Schraff SA, Johnson RF, Rutter MJ. Salivary gland surgery for chronic pulmonary aspiration in children. Int J Pediatr Otorhinolaryngol 2007; 71: 119–23.
    1. Hartzell LD, Guillory RM, Munson PD, Dunham AK, Bower CM, Richter GT. Tongue base suspension in children with cerebral palsy and obstructive sleep apnea. Int J Pediatr Otorhinolaryngol 2013; 77: 534–7.
    1. Myatt HM, Beckenham EJ. The use of diagnostic sleep nasendoscopy in the management of children with complex upper airway obstruction. Clin Otolaryngol Allied Sci 2000; 25: 200–8.
    1. Hsiao KH, Nixon GM. The effect of treatment of obstructive sleep apnea on quality of life in children with cerebral palsy. Res Dev Disabil 2007; 29: 133–40.
    1. McMillan LE, Dudhniwala AG, Ahuja S. Is there a correlation between gross motor function classification system (GMFCS) level and scoliosis in patients with cerebral palsy (CP)? A systematic review. Spine J 2016; 16: S55.
    1. Keskinen H, Lukkarinen H, Korhonen K, Jalanko T, Koivusalo A, Helenius I. The lifetime risk of pneumonia in patients with neuromuscular scoliosis at a mean age of 21 years: the role of spinal deformity surgery. J Child Orthop 2015; 9: 357–64.
    1. Blumentals WA, Nevitt A, Peng MM, Toovey S. Body mass index and the incidence of influenza‐associated pneumonia in a UK primary care cohort. Influenza Other Respir Viruses 2011; 6: 28–36.
    1. Ritz BW, Gardner EM. Malnutrition and energy restriction differentially affect viral immunity. J Nutrit 2006; 136: 1141–4.
    1. Scrimshaw NS, SanGiovanni JP. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 1997; 66: 464S–77S.
    1. dos Santos Souza, Simon MI, Drehmer M, de Abreu e Silva FA et al. Association of nutritional status, plasma, albumin levels and pulmonary function in cystic fibrosis. Nutricion Hospitalaria 2011; 26: 1322–7.
    1. Braverman J. Respiratory problems in individuals with cerebral palsy: recognition, management and prevention. Exceptional Parent 2001; 31: 56–8.
    1. Hutzler Y, Chacham A, Bergman U, Szeinberg A. Effects of a movement and swimming program on vital capacity and water orientation skills of children with cerebral palsy. Dev Med Child Neurol 1998; 40: 176–81.
    1. Rothman JG. Effects of respiratory exercises on the vital capacity and forced expiratory volume in children with cerebral palsy. Physical Therapy 1978; 58: 421–5.
    1. Shin SO, Kim NS. Upper extremity resistance exercise with elastic bands for respiratory function in children with cerebral palsy. J Phys Ther Sci 2017; 29: 2077–80.
    1. Lee HY, Cha YJ, Kim K. The effect of feedback respiratory training on pulmonary function of children with cerebral palsy: a randomized controlled preliminary report. Clin Rehabil 2014; 28: 965–71.
    1. Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease: a systematic review. Ann Periodontol 2003; 8: 54–69.
    1. Mojon P. Oral health and respiratory infection. J Can Dent Assoc 2002; 68: 340–5.
    1. Azarpazhooh A, Leake JL. Systematic review of the association between respiratory diseases and oral health. J Periodontol 2006; 77: 1465–82.
    1. Norwood K, Slayton R. Oral health care for children with developmental disabilities. Pediatrics 2013; 131: 614–9.
    1. Plioplys AV, Kasnicka I. Nebulized tobramycin: prevention of pneumonias in patients with severe cerebral palsy. J Pediatr Rehabil Med Interdiscip Appr 2011; 4: 155–8.
    1. Lephart K, Kaplan SL. Two seating systems’ effects on an adolescent with cerebral palsy and severe scoliosis. Pediatr Phys Ther 2015; 27: 258–66.
    1. Littleton SR, Heriza CB, Mullens PA, Moerchen VA, Bjornson K. Effects of positioning on respiratory measures in individuals with cerebral palsy and severe scoliosis. Pediatr Phys Ther 2011; 23: 159–69.
    1. Fitzgerald K, Dugre J, Pagala S, Homel P, Marcus M, Kazachkov M. High‐frequency chest wall compression therapy in neurologically impaired children. Resp Care 2014; 59: 107–12.
    1. Garuti G, Verucchi E, Fanelli I, Giovannini M, Winck JC, Lusuardi M. Management of bronchial secretions with free aspire in children with cerebral palsy: impact on clinical outcomes and healthcare resources. Ital J Pediatr 2016; 42: 7.
    1. Plioplys AV. Pulmonary vest therapy in pediatric long‐term care. J Am Med Dir Assoc 2002; 3: 318–21.
    1. Plioplys AV, Ebel J, Kasnicka I. Pulmonary vest therapy to prevent pneumonia in quadriplegic cerebral palsy. Arch Phys Med Rehabil 2003; 84: E6.
    1. Yuan N, Kane P, Shelton K, Matel J, Becker BC, Moss RB. Safety, tolerability, and efficacy of high‐frequency chest wall oscillation in pediatric patients with cerebral palsy and neuromuscular diseases: an exploratory randomized controlled trial. J Child Neurol 2010; 25: 815–21.
    1. Siriwat R, Deerojanawong J, Sritippayawan S, Hantragool S, Cheanprapai P. Mechanical insufflation‐exsufflation versus conventional chest physiotherapy in children with cerebral palsy. Respir Care 2018; 63: 187–93.
    1. Adams MS. The management of feeding difficulties in children with cerebral palsy in Bangladesh. London, UK: University College London, 2009.
    1. Adams MS, Khan NZ, Begum SA, Wirz SL, Hesketh T, Pring TR. Feeding difficulties in children with cerebral palsy: low‐cost caregiver training in Dhaka, Bangladesh. Child Care Health Dev 2012; 38: 878–88.
    1. Romero RG, Arnal IG, Montañés MJR, et al. Evaluación de la disfagia. Resultados tras un año de la incorporación de la videofluoroscopia en nuestro centro. An Pediatr (Barc) 2017; 89: 92–7.
    1. Miyazawa R, Tomomasa T, Kaneko H, Arakawa H, Shimizu N, Morikawa A. Effects of pectin liquid on gastroesophageal reflux disease in children with cerebral palsy. BMC Gastroenterol 2008; 8: 11.
    1. Ishimaru Y. Efficacy of laparoscopic fundoplication for gastroesophageal reflux disease in neurologically impaired patients: postoperative quality of life and operative outcomes. Dokkyo J Med Sci 2017; 44: 141–50.
    1. O’Loughlin EV, Somerville H, Shun A, et al. Antireflux surgery in children with neurological impairment: caregiver perceptions and complications. J Pediatr Gastroenterol Nutr 2013; 56: 46–50.
    1. Sullivan PB, Juszczak E, Bachlet AM, et al. Gastrostomy tube feeding in children with cerebral palsy: a prospective, longitudinal study. Dev Med Child Neurol 2005; 47: 77–85.
    1. Sullivan PB, Morrice JS, Vernon‐Roberts A, Grant H, Eltumi M, Thomas AG. Does gastrostomy tube feeding in children with cerebral palsy increase the risk of respiratory morbidity? Arch Dis Child 2006; 91: 478–82.
    1. Cheung KM, Tse HW, Tse PWT, Chan KH. Nissen fundoplication and gastrostomy in severely neurologically impaired children with gastroesophageal reflux. Hong Kong Med J 2006; 12: 282–8.
    1. Feudtner C. Collaborative communication in pediatric palliative care: a foundation for problem‐solving and decision‐making. Pediatr Clin North Am 2007; 54: 583–607.
    1. Vemuri S, Baker L, Williams K, Hynson J. The last 2 years of life for children with severe physical disability: Observations from a tertiary paediatric centre. J Paediatr Child Health 2018; 54: 1357–61.
    1. Vickers J, Thompson A, Collins GS, Childs M, Hain R, Paediatric Oncology Nurses’ Forum/United Kingdom Children’s Cancer Study Group Palliative Care Working Group . Place and provision of palliative care for children with progressive cancer: a study by the Paediatric Oncology Nurses’ Forum/United Kingdom Children’s Cancer Study Group Palliative Care Working Group. J Clin Oncol 2007; 25: 4472–6.
    1. Abernethy AP, Currow DC, Fazekas BS, Luszcz MA, Wheeler JL, Kuchibhatla M. Specialized palliative care services are associated with improved shor‐ and long‐term caregiver outcomes. Support Care Cancer 2008; 16: 585–97.
    1. Hammes BJ, Klevan J, Kempf M, Williams MS. Pediatric advance care planning. J Palliat Med 2005; 8: 766–73.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi